FHIT Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-FHIT antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | FHIT |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | 1.0 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The antibody detects endogenous levels of total FHIT protein. Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP. Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5. Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways. Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis. Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, bu |
| Immunogen | Immunogen Type: Peptide Immunogen Description: Synthesized peptide derived from human FHIT. |
| Other Names | [AP3Aase; FRA3B; bis(5'-adenosyl)-triphosphatase; inucleosidetriphosphatase; AP3A HYDROLASE FRAGILE SITE 3p14.2] |
| Gene, Accession # | [FHIT], Gene ID: 2272, NCBI: NP_001159715.1, UniProt: P49789 |
| Catalog # | MBS9407743 |
| Price | $200, $255 |
| Order / More Info | FHIT Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies